Guiyang Xintian Pharmaceutical Co.,Ltd. (002873.SZ)
CNY 8.65
(0.7%)
CNY 8.65
(0.7%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 463.77 Million CNY | 20.3% |
| 2022 | 385.5 Million CNY | 7.89% |
| 2021 | 357.3 Million CNY | 52.47% |
| 2020 | 234.34 Million CNY | 221.84% |
| 2019 | 72.81 Million CNY | -0.97% |
| 2018 | 73.52 Million CNY | 36.15% |
| 2017 | 54 Million CNY | -58.37% |
| 2016 | 129.71 Million CNY | -17.23% |
| 2015 | 156.7 Million CNY | 7.88% |
| 2014 | 145.26 Million CNY | 15.46% |
| 2013 | 125.81 Million CNY | 94.09% |
| 2012 | 64.82 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | 574.12 Million CNY | -6.72% |
| 2024 Q2 | 623.87 Million CNY | 8.9% |
| 2024 Q1 | 572.87 Million CNY | 23.53% |
| 2023 Q3 | 467.67 Million CNY | -5.53% |
| 2023 Q4 | 463.77 Million CNY | -0.84% |
| 2023 FY | 463.77 Million CNY | 20.3% |
| 2023 Q1 | 431.3 Million CNY | 11.88% |
| 2023 Q2 | 495.03 Million CNY | 14.78% |
| 2022 Q3 | 333.45 Million CNY | 4.24% |
| 2022 Q2 | 319.88 Million CNY | 3.89% |
| 2022 Q1 | 307.89 Million CNY | -13.83% |
| 2022 FY | 385.5 Million CNY | 7.89% |
| 2022 Q4 | 385.5 Million CNY | 15.61% |
| 2021 FY | 357.3 Million CNY | 52.47% |
| 2021 Q4 | 357.3 Million CNY | -1.4% |
| 2021 Q2 | 177.62 Million CNY | -43.54% |
| 2021 Q1 | 314.57 Million CNY | 34.24% |
| 2021 Q3 | 362.38 Million CNY | 104.02% |
| 2020 Q4 | 234.34 Million CNY | -15.42% |
| 2020 FY | 234.34 Million CNY | 221.84% |
| 2020 Q1 | 258.79 Million CNY | 255.41% |
| 2020 Q2 | 210.82 Million CNY | -18.53% |
| 2020 Q3 | 277.05 Million CNY | 31.41% |
| 2019 Q2 | 4.05 Million CNY | -95.06% |
| 2019 FY | 72.81 Million CNY | -0.97% |
| 2019 Q4 | 72.81 Million CNY | 152.03% |
| 2019 Q3 | 28.89 Million CNY | 613.32% |
| 2019 Q1 | 81.95 Million CNY | 17.4% |
| 2018 Q1 | 79.05 Million CNY | 46.39% |
| 2018 Q2 | 58.67 Million CNY | -25.78% |
| 2018 FY | 73.52 Million CNY | 36.15% |
| 2018 Q3 | 86.16 Million CNY | 46.86% |
| 2018 Q4 | 69.8 Million CNY | -18.99% |
| 2017 Q4 | 54 Million CNY | 159.78% |
| 2017 FY | 54 Million CNY | -58.37% |
| 2017 Q1 | 112.63 Million CNY | -13.17% |
| 2017 Q2 | -128.71 Million CNY | -214.28% |
| 2017 Q3 | -90.33 Million CNY | 29.82% |
| 2016 Q1 | 42.89 Million CNY | -72.63% |
| 2016 Q4 | 129.71 Million CNY | 0.0% |
| 2016 FY | 129.71 Million CNY | -17.23% |
| 2016 Q2 | 153.69 Million CNY | 258.29% |
| 2015 Q3 | 156.7 Million CNY | -9.12% |
| 2015 Q4 | 156.7 Million CNY | 0.0% |
| 2015 Q2 | 172.43 Million CNY | 0.0% |
| 2015 Q1 | 172.43 Million CNY | 18.71% |
| 2015 FY | 156.7 Million CNY | 7.88% |
| 2014 FY | 145.26 Million CNY | 15.46% |
| 2014 Q4 | 145.26 Million CNY | 0.0% |
| 2014 Q3 | 145.26 Million CNY | 0.0% |
| 2014 Q1 | 22.78 Million CNY | 0.0% |
| 2013 FY | 125.81 Million CNY | 94.09% |
| 2012 FY | 64.82 Million CNY | 0.0% |